已收盤 11-20 16:00:00 美东时间
-0.270
-1.26%
Amneal Pharmaceuticals' biosimilar Adcomfo (omalizumab), developed as a biosimilar to XOLAIR, has received European Commission marketing authorization, following UK MHRA approval in March 2026. Adcomfo is approved for treating severe persistent allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic spontaneous urticaria. Clinical studies demonstrated biosimilarity to the reference product, with comparable efficacy and safety. The ...
11-17 21:05
数据显示,SRHQ前十大重仓股合计占基金资产的20.147%。 其中,第一大重仓股为休曼纳,持仓占比2.7237%;第二大重仓股为Centene Corp,占比...
11-15 07:24
数据显示,SPDR 标普制药指数 ETF前十大重仓股合计占基金资产的26.4374%。 其中,第一大重仓股为Xeris Biopharma Holdings,...
11-13 07:26
今日重点评级关注:康托·菲茨杰拉德:维持Supernus"超配"评级,目标价从67美元升至87美元;丰业银行:维持Atlas Energy Solutions"跑赢大市"评级,目标价从17美元升至18美元
11-05 14:06
JP Morgan analyst Chris Schott maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight and raises the price target from $24 to $25.
11-05 03:27
Amneal Pharmaceuticals (NASDAQ:AMRX) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.be...
11-03 22:19
今日重点评级关注:富国银行:维持Helus Pharma"超配"评级,目标价从16美元升至22美元;美银证券:维持SpaceX"买入"评级,目标价从235美元升至275美元
10-23 12:30
JP Morgan analyst Chris Schott maintains Amneal Pharmaceuticals (NASDAQ:AMRX) with a Overweight and raises the price target from $22 to $24.
10-22 21:40
As investors look beyond the largest companies for potential opportunities, Oppenheimer Equity Research has updated its list of SMID-cap ideas for Fall 2026, highlighting a group of companies across t...
10-06 21:09
今日重点评级关注:Leerink Partners:维持塞德斯医疗"跑赢大市"评级,目标价从70美元升至88美元;HC Wainwright & Co.:维持TriSalus Life Sciences"买入"评级,目标价从11美元升至12美元
09-24 16:10